Confident Investing Starts With TipRanks Premium

Get 55% Off
TipRanks
Go Ultimate55% OFF

Vaxxinity Inc (VAXX) Stock Price & Analysis

VAXX Stock Chart & Stats

$0.02$0.01(14900.00%)
At close: 10:26 AM EST
$0.025$0.056 Aug27 Aug8 Sep17 Sep5 Oct13 Oct2 Nov
Day’s Range
$0.02 - $0.02
52-Week Range
$0.01 - $0.06
Previous Close
$0.03
Volume
N/A
Average Volume (3M)
584
Market Cap
$14.07K
Enterprise Value
$92.39M
Total Cash (Recent Filing)
$30.39M
Total Debt (Recent Filing)
$15.17M
Price to Earnings (P/E)
―
Beta
486.54
Next Earnings
N/A
EPS Estimate
N/A
Next Dividend Ex-Date
N/A
Dividend Yield
N/A

Bulls Say, Bears Say

Bulls Say

Innovative Vaccine Platform

Vaxxinity's innovative platform for developing vaccines positions it well in the biotechnology sector, potentially transforming treatment landscapes for chronic diseases.

Strategic Collaborations

Strategic collaborations and partnerships can enhance Vaxxinity's market reach and provide essential funding, aiding in the development and commercialization of its products.

Cash Position

A strong cash position provides Vaxxinity with a liquidity cushion, allowing it to navigate financial challenges and invest in R&D for future growth.

Bears Say

High Financial Leverage

High financial leverage can strain Vaxxinity's financial stability, increasing risk and potentially limiting its ability to invest in growth opportunities.

Lack Of Revenue Growth

The absence of revenue growth and ongoing losses highlight challenges in monetizing products, which could hinder long-term sustainability and investor confidence.

Negative Cash Flows

Negative cash flows indicate operational inefficiencies and financial strain, potentially impacting Vaxxinity's ability to fund its R&D and operational activities.

Vaxxinity Inc News

VAXX FAQ

What was Vaxxinity Inc’s price range in the past 12 months?
Vaxxinity Inc lowest stock price was $0.01 and its highest was $0.06 in the past 12 months.
What is Vaxxinity Inc’s market cap?
Vaxxinity Inc’s market cap is $14.07K.
When is Vaxxinity Inc’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Vaxxinity Inc’s earnings last quarter?
Vaxxinity Inc released its earnings results on Mar 27, 2024. The company reported -$0.09 earnings per share for the quarter, beating the consensus estimate of -$0.1 by $0.01.
Is Vaxxinity Inc overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does Vaxxinity Inc pay dividends?
Vaxxinity Inc does not currently pay dividends.
What is Vaxxinity Inc’s EPS estimate?
Vaxxinity Inc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Vaxxinity Inc have?
Vaxxinity Inc has 126,784,680 shares outstanding.
What happened to Vaxxinity Inc’s price movement after its last earnings report?
Vaxxinity Inc reported an EPS of -$0.09 in its last earnings report, beating expectations of -$0.1. Following the earnings report the stock price went up 25%.
Which hedge fund is a major shareholder of Vaxxinity Inc?
Currently, no hedge funds are holding shares in VAXX
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology